References
- Goldfarb A R, Weimer L H, Brannagan T H, III. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy. Muscle Nerve 2005; 31: 510–515
- Nobile-Orazio E. IgM paraproteinaemic neuropathies. Curr Opin Neurol 2004; 17: 599–605
- Eurelings M, Ang C W, Notermans N C, Van Doorn P A, Jacobs B C, Van den Berg L H. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 2001; 27: 1909–1912
- Kilidireas C, Anagnostopoulos A, Karandreas N, Mouselimi L, Dimopoulos M A. Rituximab therapy in monoclonal IgM-related neuropathies. Leuk Lymphoma 2006; 47: 859–864
- Rojas-Garcia R, Gallardo E, de Andres I, de Luna N, Juarez C, Sanchez P, et al. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab. Neurology 2003; 23: 1814–1816
- Broglio L, Lauria G. Worsening after rituximab treatment in anti-mag neuropathy. Muscle Nerve 2005; 32: 378–379